Rebentisch G, Stolz S, Muche J
Carl-Thiem-Klinikum Cottbus, Institut für Klinische Chemie und Laboratoriumsdiagnostik.
Aktuelle Urol. 2004 Jun;35(3):215-21. doi: 10.1055/s-2004-818370.
It is the intention of this report to identify appropriate analytical tests which allow for the monitoring of allopurinol treatment of patients with Lesch-Nyhan syndrome and the prevention of uric acid or xanthine lithiasis.
A 12 year old boy with Lesch-Nyhan syndrome presented with signs of compulsive automutilation, motoric and mental retardation and cerebral palsy. Paraclinical patient showed hyperuricemia and significant hyperuricosuria. During administration of allopurinol (200 mg/d) he developed fever, an urinary tract infection and dilatation of pelviureteric junction which was suspected of being nephrolithiasis. During hospitalisation, the purine metabolism was intensively monitored. The allopurinol treatment was adjusted according to clinical and laboratory data.
The renal scanning diagnostic showed the develepment of a functionally impaired left kidney. Later this kidney had no part in tubulo-secretorical function. It was necessary to remove surgical two renal stones. The composition of the stones was exclusively xanthine. Serum concentration and urinary excretion of xanthine and hypoxanthine were massively enlarged. The elimination of uric acid in urine was normal. But subsequently, the left kidney had to be removed despite intensive care.
Lesch-Nyhan syndrome is a disorder caused by congenital absence of the enzyme hypoxanthineguanine phosphoribosyltransferase and an increase of the enzyme activity of adenine phosphoribosyltransferase. Treatment should be adjusted to patient's age and weight. An adapt treatment with allopurinol and optimal fluid intake reduce the risk of uric acid or xanthine lithiasis. Laboratory monitoring includes testings for serum concentration and urinary excretion of uric acid, xanthine and hypoxanthine. Sole a normal concentration of uric acid is not sufficient for therapy control. Assessment of the urine sediment by microscopy or infrared spectroscopy will enable early detection of uric acid or xanthine lithiasis.
本报告旨在确定合适的分析测试方法,以监测莱施-奈汉汉尼汉综合征患者的别嘌醇治疗情况,并预防尿酸或黄嘌呤结石形成。
一名12岁莱施-尼汉综合征男孩,有强迫性自残、运动和智力发育迟缓以及脑瘫症状。辅助检查显示患者有高尿酸血症和显著的高尿酸尿症。在服用别嘌醇(200毫克/天)期间,他出现发热、尿路感染以及肾盂输尿管连接处扩张,怀疑为肾结石。住院期间,对嘌呤代谢进行了密切监测。根据临床和实验室数据调整别嘌醇治疗方案。
肾脏扫描诊断显示左肾功能受损。后来该肾脏不再参与肾小管分泌功能。有必要通过手术取出两颗肾结石。结石成分仅为黄嘌呤。黄嘌呤和次黄嘌呤的血清浓度及尿排泄量大幅增加。尿酸的尿排泄正常。但随后,尽管进行了精心护理,左肾仍不得不被切除。
莱施-尼汉综合征是一种由先天性次黄嘌呤-鸟嘌呤磷酸核糖转移酶缺乏以及腺嘌呤磷酸核糖转移酶活性增加引起的疾病。治疗应根据患者年龄和体重进行调整。采用别嘌醇的适应性治疗和最佳液体摄入量可降低尿酸或黄嘌呤结石形成的风险。实验室监测包括检测尿酸、黄嘌呤和次黄嘌呤的血清浓度及尿排泄量。仅尿酸浓度正常不足以控制治疗。通过显微镜检查或红外光谱法评估尿沉渣将有助于早期发现尿酸或黄嘌呤结石。